APA (7th ed.) Citation

B, B., R, T., DL, H., R, B., M, A., A, B., . . . A, D. (2023). TEG-based transfusion protocol is associated with decreased blood product use without increased risk of hemoperitoneum. Hepatology communications, 7(11), . https://doi.org/10.1097/HC9.0000000000000292

Chicago Style (17th ed.) Citation

B, Bromfield, et al. "TEG-based Transfusion Protocol Is Associated with Decreased Blood Product Use Without Increased Risk of Hemoperitoneum." Hepatology Communications 7, no. 11 (2023). https://doi.org/10.1097/HC9.0000000000000292.

MLA (9th ed.) Citation

B, Bromfield, et al. "TEG-based Transfusion Protocol Is Associated with Decreased Blood Product Use Without Increased Risk of Hemoperitoneum." Hepatology Communications, vol. 7, no. 11, 2023, https://doi.org/10.1097/HC9.0000000000000292.